Histiocytosis - 49 Studies Found
| Completed |
: A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis : Langerhans Cell Histiocytosis : 2011-07-12 : Drug: GSK2110183 Drug will be administered as 125 mg capsules once daily. |
| Completed |
: Assessment of Safety of Air Travel in Patients With Pulmonary Langerhans Cell Histiocytosis : Pulmonary Langerhans Cell Histiocytosis : 2017-02-09 |
| Active, not recruiting |
: Evaluation of Efficacy and Tolerance of Cladribine in Symptomatic Pulmonary Langerhans Cell Histiocytosis : Langerhans Cell Histiocytosis of Lung : 2011-10-14 : Drug: Cladribine Subcutaneous injections, 0,1 mg/kg/day for 5 days, one course per month for 4 months |
| Completed |
: Prospective Evaluation of Adult Pulmonary Langerhans Cell Histiocytosis : Adult Pulmonary Langerhans Cell Histiocytosis : 2010-10-12 : Behavioral: Tabacco discontinuation Tabacco discontinuation |
| Completed |
: Cardiovascular Risk Factors and LCH in Adults : Histiocytosis, Langerhans-Cell : 2007-06-06 |
| Completed |
: Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCH : Langerhans Cell Histiocytosis : 2007-12-26 :
|
| Withdrawn |
: Clofarabine for Langerhans in Pedi : Langerhans Cell Histiocytosis : 2013-02-19 : Drug: Clofarabine |
| Completed |
: Search Elevated Serum Alkaline Phosphatase as a Marker of Prenatal Intervillositis Chronic Histiocytic : Chronic Histiocytosis : 2016-01-26 |
| Completed |
: Ceftriaxone in Non-neutropenic Fever :
: 2010-10-15 |
| Completed |
: H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis : Leukemia : 2007-06-14 :
|